Jeffrey S. Points Purchases 1,600 Shares of Shoulder Innovations (NYSE:SI) Stock

Key Points

• Jeffrey Points, CFO of Shoulder Innovations, purchased 1,600 shares of the company stock at an average price of $15.67 per share, totaling approximately $25,072, increasing his holdings to 52,445 shares worth around $821,813.
• The stock of Shoulder Innovations experienced a recent decline, trading at $14.97 with a market capitalization of $227.99 million and a price-to-earnings ratio of -0.50.
• Recent analyst upgrades include moving Shoulder Innovations to a "hold" rating, with price targets set by various firms, averaging $19.60 and indicating a consensus rating of "Moderate Buy".

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CFO Jeffrey S. Points bought 1,600 shares of Shoulder Innovations stock in a transaction on Friday, September 12th. The shares were purchased at an average price of $15.67 per share, for a total transaction of $25,072.00. Following the acquisition, the chief financial officer directly owned 52,445 shares in the company, valued at approximately $821,813.15. This trade represents a 3.15% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Shoulder Innovations Trading Up 0.8%

Shares of SI stock traded up $0.12 during midday trading on Friday, reaching $14.76. 845,144 shares of the stock were exchanged, compared to its average volume of 157,488. Shoulder Innovations, Inc. has a 1 year low of $11.75 and a 1 year high of $17.94.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on SI shares. Zacks Research upgraded Shoulder Innovations to a "hold" rating in a report on Tuesday, August 26th. Wall Street Zen upgraded Shoulder Innovations from a "sell" rating to a "hold" rating in a report on Saturday, September 13th. The Goldman Sachs Group began coverage on Shoulder Innovations in a report on Monday, August 25th. They set a "buy" rating and a $20.00 target price on the stock. Jefferies Financial Group began coverage on Shoulder Innovations in a research note on Monday, August 25th. They issued a "buy" rating and a $19.00 price target on the stock. Finally, Piper Sandler began coverage on Shoulder Innovations in a research note on Monday, August 25th. They issued an "overweight" rating and a $18.00 price target on the stock. Five analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $19.60.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.